MetLife (MET) Proxy filing summary

Executive summary

• Entered the second year of a five-year New Frontier strategy focused on growth, leveraging talent, technology, and financial strength, with strong execution in the inaugural year, including major transactions, an asset management acquisition, and enhanced financial reporting transparency.

• Achieved double-digit Core Adjusted EPS growth (10%), Core Adjusted ROE of 16%, and Core FCF Ratio of 81% in 2025, exceeding targets and returning ~$4.4 billion to shareholders.

• Completed the acquisition of PineBridge Investments, expanded asset management, and executed strategic reinsurance transactions to manage risk and maximize capital.

• Board welcomed two new independent directors and saw the retirement of two long-serving members, maintaining a robust succession and refreshment process.

Voting matters and shareholder proposals

• Shareholders will vote on the election of 11 director nominees for one-year terms, ratification of Deloitte & Touche LLP as independent auditor for 2026, and an advisory vote on executive compensation.

• Board recommends voting FOR all director nominees, auditor ratification, and executive compensation.

• Shareholders have rights to call special meetings and proxy access for director nominations.

Board of directors and corporate governance

• Board consists of a majority of independent directors, with an independent Chairman and fully independent principal standing committees.

• Robust director succession planning, mandatory retirement age, and regular board/committee evaluations ensure ongoing refreshment and alignment with strategy.

• Directors possess diverse competencies in leadership, governance, insurance, global markets, risk, technology, and sustainability.

• Comprehensive orientation and continuing education programs for directors.